Laboratory surveillance of Shiga toxin-producing Escherichia coli in South Australia and the Hunter Health Area, New South Wales, Australia
DOI:
https://doi.org/10.33321/cdi.2004.28.43Keywords:
Shiga toxin, Escherichia coli, AustraliaAbstract
To estimate the prevalence of shiga toxin producing Escherichia coli in Australia, bloody stool samples from two Australian locations were screened for the presence of shiga toxin genes, stx1 and stx2. Four of 126 (3.2%) and 139 of 5,829 (2.4%) patients from the two locations had a positive Polymerase Chain Reaction for shiga toxin genes. Commun Dis Intell 2004;28:390–391.
Downloads
References
Elliott EJ, Robins-Browne RM, O'Loughlin EV, Bennett-Wood V, Bourke J, Henning P, et al. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 2001;85(2):125–131.
Verweyen HM, Karch H, Brandis M, Zimmerhackl LB. Enterohemorrhagic Escherichia coli infections: following transmission routes. Pediatr Nephrol 2000;14(1):73–83.
Fey PD, Wickert RS, Rupp ME, Safranek TJ, Hinrichs SH. Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrhoeal stool samples from Nebraska. Emerg Infect Dis 2000;6(5):530–533.
Klein EJ, Stapp JR, Clausen CR, Boster DR, Wells JG, Qin X, et al. Shiga toxin-producing Escherichia coli in children with diarrhoea: a prospective point-of-care study. J Pediatr 2002;141(2):172–177.
Leelaporn A, Phengmak M, Eampoklap B, Manatsathit S, Tritilanunt S, Siritantikorn S, et al. Shiga toxin- and enterotoxin-producing Escherichia coli isolated from subjects with bloody and non-bloody diarrhoea in Bangkok, Thailand. Diagn Microbiol Infect Dis 2003;46(3):173–180.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2004 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
